12+ is the median overall survival. mOS is the length of time at which 50% of the patients are still alive. For Trodelvy the mOS was 11.8 months which is the best out there. We were over 12 months at the point the data was checked for the analysis and may still be. Which is why there is no reason for the FDA not to give us a BTD.